Anastrozol - off‑label použití u mužů

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Anastrozole - off-label use in men
Authors

TURJAP Miroslav KRÁL Roman JUŘICA Jan

Year of publication 2023
Type Article in Periodical
Magazine / Source Farmacie pro praxi - Praktické lékárenství
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.solen.cz/artkey/lek-202301-0002_anastrozol_-_off_8209_label_pouziti_u_muzu.php
Keywords anastrozole; aromatase inhibitors; men; off-label use; clinical trials
Description Anastrozole is a highly selective nonsteroidal aromatase inhibitor. It is approved for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Nonetheless, aromatase inhibitors have also been used off-label for many years in men. This article outlines empirical non-oncological anastrozole uses in men and briefly presents some current clinical trials involving the male population.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.